Cellular Immunotherapy Market Size & Growth Forecast 2026–2035, By Segments (End-use, Therapy Type, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Chapter 1. Methodology and Scope

• Methodology segmentation & scope
• Market Definitions
• Research Methodology
• Research Scope and Assumptions

Chapter 2. Executive Summary

• Market Outlook
• Segment Outlook
• Competitive Insights

Chapter 3. Cellular Immunotherapy Industry Insights

• Market Introduction
• Industry Value Chain Analysis
• Market Dynamics
  • Market Drivers Analysis
  • Market Restraints Analysis
  • Industry Opportunities
• Regulatory Framework
• Analysis Tools
  • Porter’s Analysis
    • Bargaining Power of the Suppliers
    • Bargaining Power of the Buyers
    • Threats of Substitution
    • Threats From New Entrants
  • PESTEL Analysis
    • Political Landscape
    • Economic and Social Landscape
    • Technological Landscape
    • Environmental Landscape
    • Legal Landscape

Chapter 4. Cellular Immunotherapy Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by End-use

• Hospitals Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Cancer Institutes Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 5. Cellular Immunotherapy Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Therapy Type

• CAR T Cell Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Dendritic Cell Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• NK Cell Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• TIL Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 6. Cellular Immunotherapy Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Indication

• B-cell Malignancies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Prostate Cancer Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Liver Cancer Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Renal Cell Carcinoma Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 7. Cellular Immunotherapy Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Region & Countries

• Cellular Immunotherapy Share, By Region
• North America
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • U.S.
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Canada
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
• Europe
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • UK
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Germany
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • France
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Italy
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Spain
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Russia
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
• Asia Pacific
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • China
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • India
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Japan
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Australia
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • South Korea
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
• Latin America
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Mexico
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Brazil
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Argentina
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
• Middle East & Africa
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • Saudi Arabia
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • UAE
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)
  • South Africa
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Therapy Type, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Indication, 2022–2035 (USD Billion)

Chapter 8. Competitive Landscape

• Company Overview
• Company Market Share Analysis
• Company Heat Map Analysis
• Company SWOT Analysis
• Company Financial Performance
• Strategy Mapping
  • Expansion
  • Mergers & Acquisition
  • Partnerships & Collaborations
  • New Product Launches
  • Research and Development
• Company Profiles
  • Bristol-Myers Squibb Company (United States)
  • Novartis AG (Switzerland)
  • Gilead Sciences Inc. (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Merck KGaA (Germany)
  • GlaxoSmithKline plc (United Kingdom)
  • AstraZeneca plc (United Kingdom)
  • Pfizer Inc. (United States)
  • Johnson & Johnson (United States)
  • Celyad Oncology SA (Belgium)

List of Tables

• Global Cellular Immunotherapy Market, 2022–2035 (USD Billion)
• Global Cellular Immunotherapy Market, by Region, 2022–2035 (USD Billion)
• Global Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Global Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Global Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Hospitals Segment by Region, 2022–2035 (USD Billion)
• Cancer Institutes Segment by Region, 2022–2035 (USD Billion)
• Others Segment by Region, 2022–2035 (USD Billion)
• CAR T Cell Therapy Segment by Region, 2022–2035 (USD Billion)
• Dendritic Cell Therapy Segment by Region, 2022–2035 (USD Billion)
• NK Cell Therapy Segment by Region, 2022–2035 (USD Billion)
• TIL Therapy Segment by Region, 2022–2035 (USD Billion)
• Others Segment by Region, 2022–2035 (USD Billion)
• B-cell Malignancies Segment by Region, 2022–2035 (USD Billion)
• Prostate Cancer Segment by Region, 2022–2035 (USD Billion)
• Liver Cancer Segment by Region, 2022–2035 (USD Billion)
• Renal Cell Carcinoma Segment by Region, 2022–2035 (USD Billion)
• Others Segment by Region, 2022–2035 (USD Billion)
• North America Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• North America Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• North America Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• U.S. Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• U.S. Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• U.S. Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Canada Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Canada Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Canada Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Europe Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Europe Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Europe Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• UK Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• UK Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• UK Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Germany Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Germany Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Germany Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• France Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• France Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• France Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Italy Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Italy Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Italy Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Spain Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Spain Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Spain Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Russia Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Russia Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Russia Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Asia Pacific Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Asia Pacific Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Asia Pacific Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• China Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• China Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• China Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• India Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• India Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• India Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Japan Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Japan Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Japan Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Australia Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Australia Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Australia Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• South Korea Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• South Korea Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• South Korea Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Latin America Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Latin America Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Latin America Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Mexico Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Mexico Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Mexico Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Brazil Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Brazil Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Brazil Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Argentina Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Argentina Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Argentina Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Middle East & Africa Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Middle East & Africa Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Middle East & Africa Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• UAE Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• UAE Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• UAE Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• Saudi Arabia Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• Saudi Arabia Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• Saudi Arabia Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)
• South Africa Cellular Immunotherapy Market, by End-use, 2022–2035 (USD Billion)
• South Africa Cellular Immunotherapy Market, by Therapy Type, 2022–2035 (USD Billion)
• South Africa Cellular Immunotherapy Market, by Indication, 2022–2035 (USD Billion)

List of Figures

• Market Snapshot
• Segment Snapshot
• Competitive Landscape Snapshot
• Industry Value Chain Analysis
• Market Dynamics
• PORTER’s Analysis
• PESTEL Analysis
• Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion), by End-use
• Hospitals Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Cancer Institutes Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion), by Therapy Type
• CAR T Cell Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Dendritic Cell Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• NK Cell Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• TIL Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion), by Indication
• B-cell Malignancies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Prostate Cancer Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Liver Cancer Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Renal Cell Carcinoma Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Global Cellular Immunotherapy Market Share, by Region
• North America Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• U.S. Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Canada Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Europe Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• UK Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Germany Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• France Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Italy Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Spain Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Russia Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Asia Pacific Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• China Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• India Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Japan Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Australia Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• South Korea Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Latin America Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Mexico Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Brazil Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Argentina Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Middle East & Africa Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• UAE Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Saudi Arabia Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• South Africa Cellular Immunotherapy Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Key Company Categorization
• Company Market Positioning
• Key Company Market Share Analysis